Sep 2026· Dicle Tıp Dergisi· Vol 53, pp. 617-626· 0 citations· 6 references
TL;DR
This study evaluated the association of baseline NLR and PLR values with clinical phenotype and relapse in sarcoidosis patients between January 2014 and June 2024 and found that patients with relapse had significantly higher baseline NLR and PLR values.
Abstract
Background: Sarcoidosis is a heterogeneous multisystem granulomatous disease characterized by variable clinical course and relapse potential. Current ATS, BTS, and ERS guidance highlights the need for accessible biomarkers that may support clinical assessment and longitudinal follow up. Inflammatory hematologic indices such as neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) have been investigated as potential markers of disease activity in sarcoidosis. This study aimed to evaluate the association of baseline NLR and PLR values with clinical phenotype and relapse in sarcoidosis patients.Methods: In this single-center retrospective study, adult patients followed with a diagnosis of sarcoidosis between January 2014 and June 2024 were reviewed. Patients with concomitant infection at diagnosis, HIV infection, active malignancy, hematologic disease, coexisting tuberculosis, or missing clinical/laboratory data were excluded. Baseline complete blood count parameters were used to calculate NLR and PLR values. Relapse status during follow-up was recorded, and laboratory parameters at relapse were additionally evaluated in relapsing patients. Group comparisons, ROC analyses, and multivariate logistic regression analyses were performed to evaluate the association between inflammatory indices and relapse.Results: A total of 198 patients were included, and relapse occurred in 32 patients (16.2%). Patients with relapse had significantly higher baseline NLR (median 2.6 vs 2.1, p=0.003) and PLR (median 208.6 vs 132.3, p
Background: Sarcoidosis is a heterogeneous multisystem granulomatous disease with an unpredictable clinical course. Reliable biomarkers for predicting relapse remain limited. The Prognostic Nutritional Index (PNI), reflecting systemic inflammation and immunonutritional status, has emerged as a prognostic marker in vari...
Güzide Tomas, M. Düger, Ş. Başlılar et al.· Sarcoidosis Vasculities and...· 0 citations
Objective: Chronic obstructive pulmonary disease (COPD) is a progressive disorder characterized by systemic inflammation. The neutrophil-to-lymphocyte ratio (NLR) has emerged as an easily accessible biomarker reflecting inflammatory burden. This study aimed to investigate the association between NLR and objective and c...
Can Çolakoğlu, Sefa Levent Ozşahin· Cumhuriyet Medical Journal· 0 citations
Pulmonary thromboembolism (PTE) is a severe and potentially fatal complication in patients with malignancy. Systemic inflammation plays an important role in both cancer progression and thrombogenesis. This study aimed to evaluate the association of systemic inflammatory indices with in-hospital mortality and clinical r...
Esra Arslan Aksu, L. Özdemi̇r, Savaş Gegin et al.· Medicine· 0 citations
TRAb is the most reliable predictor of remission in GD, whereas hematological inflammatory indices do not appear to have significant predictive value, which highlights the limited clinical utility of non-specific inflammatory markers and reinforces the importance of disease-specific autoantibodies in determining progno...
Sezin Doğan Çakır, M. Adaş· European Archives of Medical...· 0 citations
Background and aim: Lung cancer is frequently associated with systemic inflammation and immune dysregulation, reflected by complete blood count (CBC)-derived indices, including the neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR). Eosinophils and basophils...
O. Savencu, Horia-Dan Lișcu, N. Verga· Cureus· 0 citations
Background: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) refer to an abrupt deterioration in airway function and respiratory symptoms among individuals with COPD. The neutrophil-to-lymphocyte ratio (NLR) is a simple, cost-effective biomarker of systemic inflammation. Early diagnosis and clinica...
Mia Parvej, S. N. Chowdhury, A. K. Chowdhury et al.· Journal of Advances in Medic...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.